Microfluidic Chip and Flow Cytometry for Examination of the Antiplatelet Effect of Ticagrelor.
10.3881/j.issn.1000-503X.15155
- Author:
Xiao-Jing HUANG
1
;
Tian-Cong ZHANG
1
;
Xue-Mei GAO
1
;
Cui HE
1
;
Xuan-Rong HUAN
1
;
Yuan LI
1
Author Information
1. Central Laboratory,Yongchuan Hospital of Chongqing Medical University,Chongqing 402160,China.
- Publication Type:Journal Article
- Keywords:
flow cytometry;
microfluidic chip;
platelet aggregation;
shear rate;
shear-induced activation;
ticagrelor
- MeSH:
Humans;
Ticagrelor/pharmacology*;
Platelet Aggregation Inhibitors/pharmacology*;
Flow Cytometry/methods*;
Microfluidics;
Platelet Aggregation
- From:
Acta Academiae Medicinae Sinicae
2023;45(2):257-263
- CountryChina
- Language:Chinese
-
Abstract:
Objective To examine the antiplatelet effect of ticagrelor by microfluidic chip and flow cytometry under shear stress in vitro. Methods Microfluidic chip was used to examine the effect of ticagrelor on platelet aggregation at the shear rates of 300/s and 1500/s.We adopted the surface coverage of platelet aggregation to calculate the half inhibition rate of ticagrelor.The inhibitory effect of ticagrelor on ADP-induced platelet aggregation was verified by optical turbidimetry.Microfluidic chip was used to construct an in vitro vascular stenosis model,with which the platelet reactivity under high shear rate was determined.Furthermore,the effect of ticagrelor on the expression of fibrinogen receptor (PAC-1) and P-selectin (CD62P) on platelet membrane activated by high shear rate was analyzed by flow cytometry. Results At the shear rates of 300/s and 1500/s,ticagrelor inhibited platelet aggregation in a concentration-dependent manner,and the inhibition at 300/s was stronger than that at 1500/s (both P<0.001).Ticagrelor at a concentration ≥4 μmol/L almost completely inhibited platelet aggregation.The inhibition of ADP-induced platelet aggregation by ticagrelor was similar to the results under flow conditions and also in a concentration-dependent manner.Ticagrelor inhibited the expression of PAC-1 and CD62P. Conclusion We employed microfluidic chip to analyze platelet aggregation and flow cytometry to detect platelet activation,which can reveal the responses of different patients to ticagrelor.
